Blog - Page 3237 of 5573

TuesdayOct 04, 2011 2:48 pm

BeaconEquity.com: Somaxon (SOMX) Shares Spike on FDA Feedback

Shares of Somaxon Pharmaceuticals Inc., a specialty pharmaceutical company, opened sharply higher in today’s trading after the company announced FDA feedback on the over-the-counter (OTC) development program for Silenor®. At last check, Somaxon shares were trading 13.75% higher at $0.91. Somaxon said that in a recent meeting with the FDA, which was also attended by Silenor partner Procter & Gamble (NYSE: PG), the agency provided clinical and regulatory guidance that offers a clear path toward an OTC version of Silenor. The company believes that the FDA’s feedback offers a chance to develop an OTC label that is tailored to Silenor’s…

TuesdayOct 04, 2011 1:38 pm

SciClone Pharmaceuticals, Inc. (SCLN) Announces Repurchase Program and Reaffirms Previously Released 2011 Financial Guidance

SciClone Pharmaceuticals, Inc., a company that engages in the development and commercialization of novel therapeutics for the treatment of oncology, infectious diseases, cardiovascular, urological, respiratory, and central nervous system disorders, announced that its Board of Directors has given approval to a program that allows the company to repurchase up to $20 million of its common stock over the next 24 month period. Also, SciClone has reaffirmed its previously released 2011 financial guidance with the understanding that any cash utilized to repurchase may decrease the year-end cash balance and that a reduction in shares outstanding may increase full year and fourth…

TuesdayOct 04, 2011 1:34 pm

PLC Systems (PLCSF) Extends EU Market Reach through Strategic Distribution Agreement

PLC Systems Inc., an innovative medical device technologies company, today announced it has inked an agreement with ACIST Medical Systems Inc., a leading developer of innovative and advanced contrast imaging systems for the cardiology and radiology fields, in which ACIST will distribute PLC’s innovative RenalGuard System™ in the EU. Per the agreement, ACIST will exclusively distribute RenalGuard in France and Germany, significantly expanding PLC’s distribution throughout Europe, where the company has received the CE mark for RenalGuard. "Today's news is a critical catalyst to enable PLC to expand the use of RenalGuard in the largest countries in Europe," Mark R.…

TuesdayOct 04, 2011 12:05 pm

IsoRay, Inc. (ISR) Featured by TinyGems

IsoRay, Inc. is utilizing its patented radioisotope technology, experienced chemists and engineers, and management team to create a medical device company focused on providing improved patient outcomes in the treatment of prostate cancer, lung cancer, ocular melanoma cancer, brain cancer, colorectal cancer, gynecological cancer, and other cancers throughout the body. Through its subsidiary, IsoRay Medical, the Company is the sole producer of FDA-cleared Cesium-131 brachytherapy seeds. IsoRay began production and sales of Cesium-131 brachytherapy seeds in October 2004. The Company is leveraging its technology to capture a leadership position in an expanded brachytherapy market. The more clinically beneficial characteristics of…

TuesdayOct 04, 2011 11:46 am

Small Cap Voice: Standard & Poor’s Initiates Factual Stock Report Coverage on Stronghold Metals, Inc. (SDMTF)

Stronghold Metals Inc., in the exploration stage as of May 31, 2011, engages in the acquisition, exploration and development of mineral properties, primarily in South America. The company’s two main projects are the Eagle Mountain Gold Project in Guyana and the Tucuma Project in Brazil. In August 2011, Stronghold entered into a letter of intent to sell the Tucuma Project to Kensington Court Ventures Inc. The Eagle Mountain Project comprises an area of approximately 5,050 hectares (12,480 acres) in central Guyana, 200 kilometers southwest of the capital, Georgetown, and 45 kilometers from the historic Omai Gold Mine. In September 2010,…

TuesdayOct 04, 2011 11:30 am

Illumina, Inc. (ILMN) Enters Research Agreement with University of North Texas

Illumina, Inc. is a leading developer and manufacturer of life science tools and systems for the analysis of genetic variation and function. The company provides innovative sequencing and array-based solutions for various analysis of DNA, RNA and protein. The company announced today it has entered into a wide-ranging collaborative research agreement with the Institute of Applied Genetics and the Department of Forensic and Investigative Genetics at the University of North Texas Health Science Center (UNTHSC). Illumina and UNTHSC will work together on several projects in forensic identification using the company's next-generation sequencing technology. The projects outlined in the agreement include…

TuesdayOct 04, 2011 11:21 am

Medizone International, Inc. (MZEI) Announces Partnership with NewsUSA

Located in San Francisco, California, Medizone International is engaged in the final production development of its modular design AsepticSure Decontamination Systems. These systems are used in an array of facilities for clean and healthy infrastructure. Today, Medizone took a major step towards prominence with the announcement that they have partnered with NewsUSA. NewsUSA has been offering guaranteed media placements and public relations services for over two decades. The company is known for providing an efficiency of scale virtually impossible to achieve with any other form of marketing. Leading the way at Medizone is Edwin Marshall whom serves as their CEO.…

TuesdayOct 04, 2011 9:12 am

Advanced Cell Technology Inc. (ACTC) is “One to Watch”

Advanced Cell Technology Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. They apply stem cell-based technologies and other proprietary methods in the field of regenerative medicine to bring patient-specific therapies from the lab to the bedside. ACTC has their headquarters in Santa Monica, California, and they have a laboratory facility in Marlborough, Massachusetts. The Company has three cellular product platforms based on innovative stem cell technology. They are focusing on commercializing their Retinal Pigment Epithelial (RPE) therapy for degenerative retinal disease. The Company has recently initiated two Phase 1/2 clinical trials. They are also…

MondayOct 03, 2011 5:17 pm

CC Media Holdings, Inc. (CCMO) Names Former Head of MTV New CEO to Oversee Global Media Properties and Outdoor Holdings

CC Media Holdings, Inc., a leading global media, digital and entertainment company, announced today the selection of Bob Pittman as the new Chief Executive Officer to run both the radio company Clear Channel Communications and the advertiser Clear Channel Outdoor. Pittman, the co-founder and former CEO of MTV networks, starts as CEO of the San Antonio based company effective immediately. Mark Mays, the former CEO of CC Media, will remain with the company as Chairman of the parent company and John Hogan, the head of Clear Channel Radio, will also remain with the company. “Over the past year, I’ve had…

MondayOct 03, 2011 3:04 pm

Ecoland International, Inc. (ECIT) Signs Letter to Acquire D&R Tech

Today, Ecoland International, Inc. announced that they signed a letter of intent to acquire D&R Technology. According to the terms of the letter, D&R shareholders would receive shares of Ecoland with D&R management staying in place. D&R Technology is a producer of automated tube processing systems for the automotive industry, handling design and manufacturing of said systems. D&R products are used by three of the top ten automotive part suppliers in the world. The company also provides custom-built tooling, process development, production support, and preventive maintenance. Ecoland is interested in D&R from a growth standpoint. The goal for D&R is…

Site Search

Company Search